BioNxt Solutions Inc. (OTCMKTS:BNXTF) Sees Large Drop in Short Interest

BioNxt Solutions Inc. (OTCMKTS:BNXTFGet Free Report) was the recipient of a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 1,000 shares, a drop of 93.3% from the February 28th total of 15,000 shares. Based on an average trading volume of 16,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are sold short.

BioNxt Solutions Stock Down 9.3 %

Shares of BNXTF traded down $0.04 during trading hours on Thursday, reaching $0.39. The company’s stock had a trading volume of 200 shares, compared to its average volume of 10,215. The company has a 50 day moving average of $0.34 and a two-hundred day moving average of $0.25. The firm has a market cap of $44.50 million, a price-to-earnings ratio of -9.81 and a beta of 0.62. BioNxt Solutions has a 1-year low of $0.11 and a 1-year high of $0.43.

About BioNxt Solutions

(Get Free Report)

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.

Featured Articles

Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.